Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

New antibiotic isolated and characterized at the Institute of Microbial Chemistry in Tokyo

Jan. 13, 1999

Nankai University team describes new compound with antileukemia activity

Jan. 13, 1999

Hybridon develops antisense oligonucleotides to thymidylate synthase

Jan. 13, 1999

Quinazolinones as farnesyltransferase inhibitors in early development at Janssen

Jan. 12, 1999

Spanish university research team discovers new alkaloids with antitumor properties

Jan. 12, 1999

IFN-gamma gene transfer to autologous melanoma tumor cells feasible, but further work needed

Jan. 11, 1999

Cell Pathways confirms novel mechanism of action of exisulind, CP-461 and related compounds

Jan. 11, 1999

Abgenix and AVI BioPharma to develop human antibody for cancer

Jan. 11, 1999

Ethyol for reducing radiation-induced xerostomia in head and neck cancer filed with FDA

Jan. 8, 1999

ProScript and NCI enter collaboration for development of anticancer therapeutic

Jan. 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.